Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives

In patients with type 2 diabetes mellitus (T2DM) who require additional glucose-lowering on top of first-line metformin monotherapy, sulfonylureas are the most common choice for second-line therapy followed by dipeptidyl peptidase inhibitors (DPP-4i). This article summarises presentations at a sympo...

Descripción completa

Detalles Bibliográficos
Autores principales: Khunti, Kamlesh, Hassanein, Mohamed, Lee, Moon-Kyu, Mohan, Viswanathan, Amod, Aslam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415040/
https://www.ncbi.nlm.nih.gov/pubmed/32440835
http://dx.doi.org/10.1007/s13300-020-00833-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415040/
https://www.ncbi.nlm.nih.gov/pubmed/32440835
http://dx.doi.org/10.1007/s13300-020-00833-x

Ejemplares similares